Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

The association of proton pump inhibitors and chronic kidney disease

cause or confounding?

Li, Tingtinga,b; Xie, Yana; Al-Aly, Ziyada,b,c,d

Current Opinion in Nephrology and Hypertension: May 2018 - Volume 27 - Issue 3 - p 182–187
doi: 10.1097/MNH.0000000000000406
EPIDEMIOLOGY AND PREVENTION: Edited by Navdeep Tangri
Buy

Purpose of review To discuss whether the recently described relationship between proton pump inhibitor (PPI) use and the risk of adverse kidney outcomes represents a causal relationship or is merely the result of confounding.

Recent findings A wave of observational studies has described an association between PPI use and the risk of development of chronic kidney disease and its progression to end-stage renal disease. The results are generally robust and remarkably consistent across different studies. The application of modern pharmacoepidemiologic methods to estimate the effect of a putative unmeasured or unknown confounder or set of confounders on the relationship of PPI use and risk of adverse renal outcomes suggests that confounding is unlikely to explain away the reported association.

Summary The constellation of evidence from all available studies suggests that PPI use is associated with increased risk of adverse kidney outcomes. Exercising vigilance in the use of PPI is warranted.

aClinical Epidemiology Center, Research and Education Service, VA Saint Louis Healthcare System

bDepartment of Medicine, Washington University School of Medicine

cNephrology Section, Medicine Service, VA Saint Louis Healthcare System

dInstitute for Public Health, Washington University in Saint Louis, Saint Louis, Missouri, USA

Correspondence to Ziyad Al-Aly, MD, Clinical Epidemiology Center, Research and Education Service, VA Saint Louis Healthcare System, 915 North Grand Boulevard, 151-JC, Saint Louis, MO 63106, USA. E-mail: zalaly@gmail.com

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.